Intralesional cidofovir does not increase the risk of laryngeal dysplasia or laryngeal carcinoma
- 1 October 2008
- journal article
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 72 (10) , 1581-1582
- https://doi.org/10.1016/j.ijporl.2008.05.013
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosisEuropean Archives of Oto-Rhino-Laryngology, 2008
- Lung involvement in juvenile onset recurrent respiratory papillomatosis: A systematic review of the literatureInternational Journal of Pediatric Otorhinolaryngology, 2008
- Cidofovir for recurrent respiratory papillomatosis (RRP): A re-assessment of risksInternational Journal of Pediatric Otorhinolaryngology, 2005
- Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosisAntiviral Research, 2004
- Local and systemic effects of intralaryngeal injection of cidofovir in a canine modelThe Laryngoscope, 2003
- Intralesional Cidofovir for Recurrent Respiratory Papillomatosis in ChildrenJAMA Otolaryngology–Head & Neck Surgery, 1999
- Effect of Oral Probenecid Coadministration on the Chronic Toxicity and Pharmacokinetics of Intravenous Cidofovir in Cynomolgus MonkeysToxicological Sciences, 1998
- Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]Journal of Medical Virology, 1998